Drug recall
Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles…
FDA recall event 84019 · Class III · Sato Pharmaceutical Inc.
Key facts
| Event ID | 84019 |
|---|---|
| Recall numbers | D-0303-2020 |
| Recalling firm | Sato Pharmaceutical Inc. |
| Product type | Drugs |
| Products | Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Subpotent Drug: Formulated amount of sennosides component is less than labelled claim. |
| Initiation date | Oct 1, 2019 |
| Report date | Nov 13, 2019 |
| Termination date | Aug 18, 2020 |
| City | Torrance |
| State | CA |
| Country | United States |
| FEI number | 2082295 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: